File(s) under permanent embargo

Reason: This item is currently closed access.

Benefits and Harms of Once-weekly Glucagon-like peptide-1 receptor agonist treatments. A systematic review and network meta-analysis

journal contribution
posted on 27.10.2015, 15:57 by Melanie J. Davies, Francesco Zaccardi, Zin Zin Htike, David R. Webb, Kamlesh Khunti
Benefits and Harms of Once-weekly Glucagon-like peptide-1 receptor agonist treatments. A systematic review and network meta-analysis

History

Citation

Annals of Internal Medicine, 2015, in press

Author affiliation

/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Cardiovascular Sciences

Version

AM (Accepted Manuscript)

Published in

Annals of Internal Medicine

Publisher

American College of Physicians

issn

0003-4819

eissn

1539-3704

Acceptance date

19/10/2015

Copyright date

2015

Publisher version

http://annals.org/

Notes

The file associated with this record is under permanent embargo due to the publishers archiving policy. It may be available from PubMed Central 6 months after publication.

Language

en

Usage metrics

Categories

Keywords

Exports